學術活動1040918 FORXIGA® (dapagliflozin):New insulin-independent mechanism of SGLT2 inhibitor for Type 2 diabetes to overcome uncontrolled sugar 朱 鈺帆 / 18 9 月, 2015 FO […] 吳至行